Sarah G Injac (Sarah Garrett Injac)

Years Active: 2019-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Amir Arabzade, Yanhua Zhao, Srinidhi Varadharajan, Hsiao-Chi Chen, Selin Jessa, Bryan Rivas, Austin J Stuckert, Minerva Solis, Alisha Kardian, Dana Tlais, Brian J Golbourn, Ann-Catherine J Stanton, Yuen San Chan, Calla Olson, Kristen L Karlin, Kathleen Kong, Robert Kupp, Baoli Hu, Sarah G Injac, Madeline Ngo, Peter R Wang, Luz A De León, Felix Sahm, Daisuke Kawauchi, Stefan M Pfister, Charles Y Lin, H Courtney Hodges, Irtisha Singh, Thomas F Westbrook, Murali M Chintagumpala, Susan M Blaney, Donald W Parsons, Kristian W Pajtler, Sameer Agnihotri, Richard J Gilbertson, Joanna Yi, Nada Jabado, Claudia L Kleinman, Kelsey C Bertrand, Benjamin Deneen, Stephen C Mack
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. Cancer discovery 11 (9) (2021)
L Frank Huang, Sarah G Injac, Kemi Cui, Frank Braun, Qi Lin, Yuchen Du, Huiyuan Zhang, Mari Kogiso, Holly Lindsay, Sibo Zhao, Patricia Baxter, Adesina Adekunle, Tsz-Kwong Man, Hong Zhao, Xiao-Nan Li, Ching C Lau, Stephen T C Wong
Systems biology-based drug repositioning identifies digoxin as a potential therapy for groups 3 and 4 medulloblastoma. Science translational medicine 10 (464) (2019)

Sarah G Injac.css-eqlu8i{font-size:small;padding-left:4px;} (Sarah Garrett Injac)